Boston, MA – April 6, 2021 – SVB Leerink, a leading investment bank specializing in healthcare and life sciences, announced today that Andrew Fineberg has been hired as a Managing Director to lead the firm’s Structured Finance practice. Mr. Fineberg will be based in SVB Leerink’s New York office and will report to Dan Dubin, Vice Chairman and Global Co-Head of Investment Banking.
The new Structured Finance Group will advise the firm’s corporate, academic, and medical not-for-profit clients on royalty monetization and private cash flow and asset-based credit.
Dr. Dubin stated, “The firm warmly welcomes Andrew to the Investment Banking team. Andrew’s experience in credit and royalty monetization will expand our capital raising services as well as complement our existing M&A and ECM capabilities for our clients.”
Mr. Fineberg joins from MTS Health Partners where he led the structured finance advisory efforts, primarily focused on structuring and executing royalty monetizations, debt financings, and other credit-based transactions.
“I am thrilled to be joining the SVB Leerink team,” stated Mr. Fineberg. “The deep industry knowledge and capital markets expertise that the firm offers will help our team optimize royalty value, and structure creative credit solutions for our clients. I look forward to collaborating with such a talented group of bankers.”
SVB Leerink will continue to build out its investment banking team throughout 2021.